Importantly, ROCK–mTOR inhibitor reprogramming treatment prevented breast cancer local recurrence in mice, while ROCK–mTOR inhibitor treatment without reprogramming condition only showed a limited effect on breast cancer recurrence. This evidence concerns the gene MTOR and breast cancer.